Effects of blood triglycerides on cardiovascular and all-cause mortality: A systematic review and meta-analysis of 61 prospective studies

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Liu, Jun ^a   Zeng, Fang Fang ^a   Liu, Zhao Min ^b   Zhang, Cai Xia ^a   Ling, Wen Hua ^a   Chen, Yu Ming ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

All cause; Cardiovascular disease; Meta analysis; Mortality; Triglycerides

Indexed keywords

ALL CAUSE MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; META ANALYSIS; MORTALITY; PROSPECTIVE STUDY; QUALITY CONTROL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DATABASES, BIBLIOGRAPHIC; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TRIGLYCERIDES;

EID: 84886393470     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-159     Document Type: Review

References (36)

1. Triglycerides: how much credit do they deserve? Kohli P, Cannon CP, Med Clin North Am 2012 96 39 55 10.1016/j.mcna.2011.11.006 22391250
2. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Miller MSN, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris-Etherton PM, Lennie TA, Levi M, Mazzone T, Pennathur S, Circulation 2011 123 2292 2333 10.1161/CIR.0b013e3182160726 21502576
3. Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Borena WST, Jonsson H, Strohmaier S, Nagel G, Bjørge T, Manjer J, Hallmans G, Selmer R, Almquist M, Häggström C, Engeland A, Tretli S, Concin H, Strasak A, Stattin P, Ulmer H, Cancer Causes Control 2011 22 291 299 10.1007/s10552-010-9697-0 21140204
4. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. Hokanson JE, Austin MA, J Cardiovasc Risk 1996 3 213 219 10.1097/00043798-199604000-00014 8836866 (Pubitemid 26266496)
5. The complex role of triglycerides in cardiovascular disease. Abdel-Maksoud MF, Hokanson JE, Semin Vasc Med 2002 2 325 333 10.1055/s-2002-35403 16222622
6. The independent relationship between triglycerides and coronary heart disease. Morrison A, Hokanson JE, Vasc Health Risk Manag 2009 5 89 95 19436658
7. A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia. Collaboration APCS, Eur J Cardiovasc Prev Rehabil 2005 12 484 491 16210936
8. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Collaboration APCS, Circulation 2004 110 2678 2686 15492305
9. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. The DECODE Study Group, Diabetologia 2006 49 2837 2846 17021922
10. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Stroup DF BJ, Morton SC, Olkin I, Williamson GD, Moher D, Becher BJ, Sipe TA, Thacker SB, JAMA 2000 283 2008 2012 10.1001/jama.283.15.2008 10789670 (Pubitemid 30214957)
11. Wells GSB, O'Connell D, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses http://www.ohri.ca/ programs/clinical-epidemiology/oxford.asp
12. Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Expert Panel on Detection, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
13. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Greenland S, Longnecker MP, Am J Epidemiol 1992 135 1301 1309 1626547
14. Meta-analysis of epidemiologic dose-response data. Berlin JA, Longnecker MP, Greenland S, Epidemiology 1993 4 218 228 10.1097/00001648-199305000-00005 8512986 (Pubitemid 23159532)
15. Meta-analysis in clinical trials. DerSimonian R, Laird N, Control Clin Trials 1986 7 177 188 10.1016/0197-2456(86)90046-2 3802833 (Pubitemid 17189972)
16. Measuring inconsistency in meta-analyses. Higgins JP, Thompson SG, Deeks JJ, Altman DG, BMJ 2003 327 557 560 10.1136/bmj.327.7414.557 12958120 (Pubitemid 37088507)
17. Operating characteristics of a rank correlation test for publication bias. Begg CB, Mazumdar M, Biometrics 1994 50 1088 1101 10.2307/2533446 7786990
18. Bias in meta-analysis detected by a simple, graphical test. Egger M, Davey Smith G, Schneider M, Minder C, BMJ 1997 315 629 634 10.1136/bmj.315.7109. 629 9310563 (Pubitemid 27387172)
19. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Duval S, Tweedie R, Biometrics 2000 56 455 463 10.1111/j.0006-341X.2000.00455.x 10877304 (Pubitemid 30422636)
20. Statistical aspects of the analysis of data from retrospective studies of disease. Mantel N, Haenszel W, J Natl Cancer Inst 1959 22 719 748 13655060
21. Risk factors and mortality-a follow-up of the Oslo Health Study from 1972-73. Holme I, Tonstad S, Tidsskr Nor Laegeforen 2011 131 456 460 21383797
22. Serum lipids and their association with mortality in the elderly: a prospective cohort study. Upmeier E, Lavonius S, Lehtonen A, Viitanen M, Isoaho H, Arve S, Aging Clin Exp Res 2009 21 424 430 10.1007/BF03327441 20154511
23. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Sarwar NDJ, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V, Circulation 2007 115 450 458 10.1161/CIRCULATIONAHA.106.637793 17190864 (Pubitemid 46184196)
24. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. Hulley SB, Rosenman RH, Bawol RD, Brand RJ, N Engl J Med 1980 302 1383 1389 10.1056/NEJM198006193022503 7374696
25. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Grundy SM, Am J Cardiol 1998 81 18B 25B 10.1016/S0002-9149(98)00033-2 9526809 (Pubitemid 28113941)
26. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up. Langsted A, Freiberg JJ, Tybjaerg-Hansen A, Schnohr P, Jensen GB, Nordestgaard BG, J Intern Med 2011 270 65 75 10.1111/j.1365-2796. 2010.02333.x 21198993
27. Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ Jr, Sarnak MJ, Nally JV Jr, Nephrol Dial Transplant 2012 27 3228 3234 10.1093/ndt/gfs058 22553369
28. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD, Clin J Am Soc Nephrol 2011 6 2364 2373 10.2215/CJN.02180311 21852664
29. Adiposity, its related biologic risk factors, and suicide: a cohort study of 542,088 taiwanese adults. Chang SS, Wen CP, Tsai MK, Lawlor DA, Yang YC, Gunnell D, Am J Epidemiol 2012 175 804 815 10.1093/aje/kwr386 22427611
30. The metabolic syndrome: A high-risk state for cancer? Cowey S, Hardy RW, Am J Pathol 2006 169 1505 1522 10.2353/ajpath.2006.051090 17071576 (Pubitemid 351181984)
31. Metabolic syndrome: a novel high-risk state for colorectal cancer. Ishino K, Mutoh M, Totsuka Y, Nakagama H, Cancer Lett 2013 33 56 31 doi:10.1016/j.canlet.2012.10.012. Epub ahead of print
32. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. Samuelsson O, Attman PO, Knight-Gibson C, Larsson R, Mulec H, Weiss L, Alaupovic P, J Am Soc Nephrol 1998 9 1482 1488 9697671 (Pubitemid 28354559)
33. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. Cheng HT, Huang JW, Chiang CK, Yen CJ, Hung KY, Wu KD, J Clin Endocrinol Metab 2012 97 1268 1276 10.1210/jc.2011-2658 22337909
34. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R, Lancet 2007 370 1829 1839 18061058
35. High-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women. Stensvold I, Urdal P, Thurmer H, Tverdal A, Lund-Larsen PG, Foss OP, Eur Heart J 1992 13 1155 1163 1396823
36. Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly. Mazza A, Tikhonoff V, Schiavon L, Casiglia E, Intern Med J 2005 35 604 610 10.1111/j.1445-5994.2005.00940.x 16207260 (Pubitemid 41564407)